Common Stock, Shares, Issued of CORCEPT THERAPEUTICS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CORCEPT THERAPEUTICS INC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CORCEPT THERAPEUTICS INC Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 142,518,000, a 3.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

CORCEPT THERAPEUTICS INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 142,518,000 +4,765,000 +3.5% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 137,753,000 +3,409,000 +2.5% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 134,344,000 +3,385,000 +2.6% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 130,959,000 +3,741,000 +2.9% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 127,218,000 +4,632,000 +3.8% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 122,586,000 +2,819,000 +2.4% 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q4 2019 119,767,000 +2,929,000 +2.5% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q4 2018 116,838,000 +2,121,000 +1.8% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q4 2017 114,717,000 +2,007,000 +1.8% 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q3 2017 114,082,000 +3,201,000 +2.9% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 113,362,000 +2,881,000 +2.6% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 113,112,000 +3,441,000 +3.1% 31 Mar 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 112,710,000 +3,068,000 +2.8% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 110,881,000 +2,136,000 +2% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 110,481,000 +2,252,000 +2.1% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 109,671,000 +1,950,000 +1.8% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 109,642,000 +8,247,000 +8.1% 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q3 2015 108,745,000 +7,604,000 +7.5% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 108,229,000 +7,106,000 +7% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 107,721,000 +7,032,000 +7% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 101,395,000 +1,546,000 +1.5% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 101,141,000 +1,327,000 +1.3% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 101,123,000 +1,309,000 +1.3% 30 Jun 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 100,689,000 +875,000 +0.88% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 99,849,000 +35,000 +0.04% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 99,814,000 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 99,814,000 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 99,814,000 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 99,814,000 +15,583,000 +18% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 84,231,000 +11,827,000 +16% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q4 2010 72,404,000 31 Dec 2010 10-K 13 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.